WFL 0.00% 0.3¢ wellfully limited

Japanese Patent Office grants skin delivery patent OBJ Limited...

  1. 142 Posts.
    lightbulb Created with Sketch. 6
    Japanese Patent Office grants skin delivery patent
    OBJ Limited (ASX: OBJ) is pleased to report it has received notice from its Patent
    Attorney that the Japanese Patent Office (JPO) has now issued the Deed of Letters
    Patent for the granting of the magnetic microarray patent to OBJ.
    The Certificate of Patent, number 6046609 titled ‘Delivery of Skincare Products’
    provides OBJ and its licensees with the patent protection in Japan for its magnetic
    microarray technology in skin delivery applications, already licensed for the beauty
    and grooming market sector. The patent is effective from 25 November 2016 and will
    expire on 17 June 2031.
    The company announced the acceptance of this patent by the JPO on 28 November 2016.
    While the granting of this patent is normally a formality, the granting of a
    Japanese patent is viewed by the Company as a major step forward. The granting of
    the same patent by the US Patent Office was announced on 12 October 2016, while
    prosecution of the same patent family is continuing in Europe.
    As with the patent granted by the USA Patent Office, the Japanese patent has a life of
    20 years from the earliest filing date of the application and will be of great interest
    and value to SK-II, the Japanese based brand currently commercialising OBJ’s
    microarray technology. Other Asia-based potential partners to OBJ will also benefit
    from this patent protection.
    “Intellectual property protection is a critical activity for the company,” said Jeffery
    Edwards, the company’s Managing Director.
    “We endeavour to achieve the widest possible protection, especially in mature and
    sophisticated markets such as Japan, USA and Europe, where patent rights are
    strongly enforced by Governments.”
    This new patent further expands OBJ’s growing portfolio of granted intellectual
    property protection.


    About OBJ
    OBJ develops proprietary magnetic micro-array drug delivery and product enhancement
    technologies for the pharmaceutical, healthcare and consumer goods sectors. OBJ partners
    companies in the design and development of next generation products using physical science
    rather than chemistry to provide new levels of product performance without the cost of
    reformulation or new ingredient approvals.
    OBJ offers a portfolio of proprietary technologies and supports partners by providing IP-
    protected market exclusivity, expertise in magnetic array design, feasibility and efficacy and
    claims testing, engineering and production.
    Last edited by bobagorof: 25/01/17
 
watchlist Created with Sketch. Add WFL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.